"Hershey has seen strong demand for gum and mint products as the category benefits from functional snacking tailwinds, including GLP-1 adoption. Sales for the company's Ice Breakers mint and gum brand increased 8% over the quarter."
"Ozempic breath refers to a fishy smell in burps or bad breath, according to medical professionals. GLP-1 makers don't include bad breath as a side effect of the drugs."
"In one clinical trial, the maker of Ozempic and Wegovy, Novo Nordisk, found that roughly 9% of people taking GLP-1 medications reported 'eructation,' better known as burping. More than 40% reported nausea, and almost 25% reported vomiting as a side effect of the drugs."
Hershey is experiencing a sales boost from users of GLP-1 weight-loss drugs, as these medications lead to smaller snack portions and increased demand for breath fresheners. CEO Kirk Tanner reported an 8% sales increase for Ice Breakers mint and gum products. The side effect of bad breath associated with GLP-1 drugs, such as Ozempic and Wegovy, may explain this trend. While not officially listed as a side effect, studies show that some users report burping and nausea, which may contribute to the need for breath-freshening products.
Read at Cbsnews
Unable to calculate read time
Collection
[
|
...
]